EVAX
Price
$10.55
Change
+$2.72 (+34.69%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
49.52M
Intraday Buy/Sell Signals
HYPD
Price
$8.09
Change
+$0.31 (+3.98%)
Updated
Oct 14 closing price
Capitalization
79.86M
Intraday Buy/Sell Signals
Interact to see
Advertisement

EVAX vs HYPD

Header iconEVAX vs HYPD Comparison
Open Charts EVAX vs HYPDBanner chart's image
Evaxion A/S
Price$10.55
Change+$2.72 (+34.69%)
Volume$3.1K
Capitalization49.52M
Hyperion DeFi
Price$8.09
Change+$0.31 (+3.98%)
Volume$503.96K
Capitalization79.86M
EVAX vs HYPD Comparison Chart in %
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVAX vs. HYPD commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and HYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (EVAX: $7.84 vs. HYPD: $8.09)
Brand notoriety: EVAX and HYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 35% vs. HYPD: 61%
Market capitalization -- EVAX: $49.52M vs. HYPD: $79.86M
EVAX [@Biotechnology] is valued at $49.52M. HYPD’s [@Biotechnology] market capitalization is $79.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileHYPD’s FA Score has 0 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • HYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, EVAX is a better buy in the long-term than HYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 6 TA indicator(s) are bullish while HYPD’s TA Score has 4 bullish TA indicator(s).

  • EVAX’s TA Score: 6 bullish, 4 bearish.
  • HYPD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, EVAX is a better buy in the short-term than HYPD.

Price Growth

EVAX (@Biotechnology) experienced а +37.06% price change this week, while HYPD (@Biotechnology) price change was -13.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPD($79.9M) has a higher market cap than EVAX($49.5M). HYPD YTD gains are higher at: 5441.096 vs. EVAX (85.474). EVAX has higher annual earnings (EBITDA): -11.76M vs. HYPD (-37.19M). EVAX has more cash in the bank: 14.7M vs. HYPD (7.53M). HYPD has less debt than EVAX: HYPD (8.47M) vs EVAX (11.3M). EVAX has higher revenues than HYPD: EVAX (3.18M) vs HYPD (44.4K).
EVAXHYPDEVAX / HYPD
Capitalization49.5M79.9M62%
EBITDA-11.76M-37.19M32%
Gain YTD85.4745441.0962%
P/E RatioN/AN/A-
Revenue3.18M44.4K7,153%
Total Cash14.7M7.53M195%
Total Debt11.3M8.47M133%
FUNDAMENTALS RATINGS
HYPD: Fundamental Ratings
HYPD
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXHYPD
RSI
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
77%
Bearish Trend 8 days ago
90%
MACD
ODDS (%)
Bullish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
83%
Bearish Trend 8 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
87%
Aroon
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRVI10.190.48
+4.94%
Trevi Therapeutics
KLXE1.790.03
+1.70%
KLX Energy Services Holdings
OSCR20.690.29
+1.42%
Oscar Health
CVEO20.820.28
+1.36%
Civeo Corp
BN45.340.54
+1.21%
Brookfield Corporation

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with OPORF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+25.24%
OPORF - EVAX
54%
Loosely correlated
N/A
LPTX - EVAX
34%
Loosely correlated
+2.95%
KURA - EVAX
34%
Loosely correlated
-3.12%
ONCO - EVAX
30%
Poorly correlated
+0.82%
HYPD - EVAX
27%
Poorly correlated
+3.98%
More

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with QNTM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then QNTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
+3.98%
QNTM - HYPD
34%
Loosely correlated
+5.27%
INKT - HYPD
34%
Loosely correlated
+0.43%
CTXR - HYPD
33%
Poorly correlated
N/A
ACXP - HYPD
32%
Poorly correlated
+6.01%
VACBF - HYPD
27%
Poorly correlated
N/A
More